211 related articles for article (PubMed ID: 36251168)
21. Associations among gastroesophageal reflux disease, psychological stress, and sleep disturbances in Japanese adults.
Okuyama M; Takaishi O; Nakahara K; Iwakura N; Hasegawa T; Oyama M; Inoue A; Ishizu H; Satoh H; Fujiwara Y
Scand J Gastroenterol; 2017 Jan; 52(1):44-49. PubMed ID: 27571846
[TBL] [Abstract][Full Text] [Related]
22. Development and evaluation of a modified Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease to distinguish functional dyspepsia from non-erosive reflux disease.
Kusano M; Hosaka H; Kawada A; Kuribayashi S; Shimoyama Y; Kawamura O; Moki F
J Gastroenterol Hepatol; 2012 Jul; 27(7):1187-91. PubMed ID: 22414314
[TBL] [Abstract][Full Text] [Related]
23. Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors.
Raghunath AS; Hungin AP; Mason J; Jackson W
Aliment Pharmacol Ther; 2009 Feb; 29(4):431-9. PubMed ID: 19035981
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of hangeshashinto for treatment of GERD refractory to proton pump inhibitors : Usual dose proton pump inhibitors plus hangeshashinto versus double-dose proton pump inhibitors: randomized, multicenter open label exploratory study.
Takeuchi T; Hongo H; Kimura T; Kojima Y; Harada S; Ota K; Takeuchi N; Noguchi T; Inoue T; Murano M; Higuchi K
J Gastroenterol; 2019 Nov; 54(11):972-983. PubMed ID: 31037449
[TBL] [Abstract][Full Text] [Related]
25. Anxiety correlates with excessive air swallowing and PPI refractoriness in patients with concomitant symptoms of GERD and functional dyspepsia.
Ribolsi M; Marchetti L; Blasi V; Cicala M
Neurogastroenterol Motil; 2023 Jul; 35(7):e14550. PubMed ID: 36786093
[TBL] [Abstract][Full Text] [Related]
26. Pretreatment prediction of symptom response to proton pump inhibitor therapy.
Nagahara A; Miwa H; Asaoka D; Shimada Y; Sasaki H; Matsumoto K; Osada T; Hojo M; Watanabe S
J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():25-30. PubMed ID: 25827800
[TBL] [Abstract][Full Text] [Related]
27. Concomitant functional dyspepsia and irritable bowel syndrome decrease health-related quality of life in gastroesophageal reflux disease.
De Vries DR; Van Herwaarden MA; Baron A; Smout AJ; Samsom M
Scand J Gastroenterol; 2007 Aug; 42(8):951-6. PubMed ID: 17613924
[TBL] [Abstract][Full Text] [Related]
28. Psychological distress is not associated with treatment failure in patients with gastroesophageal reflux disease.
Boltin D; Boaz M; Aizic S; Sperber A; Fass R; Niv Y; Dickman R
J Psychosom Res; 2013 Nov; 75(5):462-6. PubMed ID: 24182636
[TBL] [Abstract][Full Text] [Related]
29. Validation of a short questionnaire in English and French for use in patients with persistent upper gastrointestinal symptoms despite proton pump inhibitor therapy: the PASS (Proton pump inhibitor Acid Suppression Symptom) test.
Armstrong D; Veldhuyzen SJ; Chung SA; Shapiro CM; Dhillon S; Escobedo S; Chakraborty BK; Mann V; Tanser L; Nevin K
Can J Gastroenterol; 2005 Jun; 19(6):350-8. PubMed ID: 15997268
[TBL] [Abstract][Full Text] [Related]
30. [The impact of proton pump inhibitors on esophageal acid exposure in gastroesophageal reflux disease].
Liang XY; Chen WN; Lan L; Wang Q; Lü YW; Lan Y
Zhonghua Nei Ke Za Zhi; 2012 Jul; 51(7):513-5. PubMed ID: 22943821
[TBL] [Abstract][Full Text] [Related]
31. Rikkunshito simultaneously improves dyspepsia correlated with anxiety in patients with functional dyspepsia: A randomized clinical trial (the DREAM study).
Tominaga K; Sakata Y; Kusunoki H; Odaka T; Sakurai K; Kawamura O; Nagahara A; Takeuchi T; Fujikawa Y; Oshima T; Kato M; Furuta T; Murakami K; Chiba T; Miwa H; Kinoshita Y; Higuchi K; Kusano M; Iwakiri R; Fujimoto K; Tack JF; Arakawa T
Neurogastroenterol Motil; 2018 Jul; 30(7):e13319. PubMed ID: 29498457
[TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics and effectiveness of lansoprazole in Japanese patients with gastroesophageal reflux disease and dyspepsia.
Kinoshita Y; Miwa H; Sanada K; Miyata K; Haruma K
J Gastroenterol; 2014 Apr; 49(4):628-37. PubMed ID: 23653056
[TBL] [Abstract][Full Text] [Related]
33. Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy.
Roorda AK; Marcus SN; Triadafilopoulos G
Dig Dis Sci; 2011 Oct; 56(10):2871-8. PubMed ID: 21512760
[TBL] [Abstract][Full Text] [Related]
34. Overlap of functional heartburn and reflux hypersensitivity with proven gastroesophageal reflux disease.
Rengarajan A; Pomarat M; Zerbib F; Gyawali CP
Neurogastroenterol Motil; 2021 Jun; 33(6):e14056. PubMed ID: 33300667
[TBL] [Abstract][Full Text] [Related]
35. Analyzing the correlation between gastroesophageal reflux disease and anxiety and depression based on ordered logistic regression.
Li Q; Duan H; Wang Q; Dong P; Zhou X; Sun K; Tang F; Wang X; Lin L; Long Y; Sun X; Tao L
Sci Rep; 2024 Mar; 14(1):6594. PubMed ID: 38503861
[TBL] [Abstract][Full Text] [Related]
36. Impact of concomitant dyspepsia and irritable bowel syndrome on symptom burden in patients with gastroesophageal reflux disease.
Lei WY; Chang WC; Wen SH; Wong MW; Hung JS; Yi CH; Liu TT; Hsu CS; Orr WC; Vaezi MF; Pace F; Hsieh TC; Chen CL
J Formos Med Assoc; 2019 Apr; 118(4):797-806. PubMed ID: 30584006
[TBL] [Abstract][Full Text] [Related]
37. Symptom profile in partial responders to a proton pump inhibitor compared with treatment-naïve patients with gastroesophageal reflux disease: a post hoc analysis of two study populations.
Vakil N; Niklasson A; Denison H; Rydén A
BMC Gastroenterol; 2014 Oct; 14():177. PubMed ID: 25304129
[TBL] [Abstract][Full Text] [Related]
38. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
Schey R; Alla SP; Midani D; Parkman HP
Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
[TBL] [Abstract][Full Text] [Related]
39. Belching: dyspepsia or gastroesophageal reflux disease?
Lin M; Triadafilopoulos G
Am J Gastroenterol; 2003 Oct; 98(10):2139-45. PubMed ID: 14572558
[TBL] [Abstract][Full Text] [Related]
40. Demography and treatment response in patients with predominant non-erosive reflux disease or functional dyspepsia.
Miwa H; Haruma K; Sakamoto S; Sanada K; Hiroi S; Kinoshita Y
J Gastroenterol Hepatol; 2015 May; 30(5):834-41. PubMed ID: 25559435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
